Meta-analysis of Incidence of Brain Cancer Among Aircrew

Document Type : Original Article

Authors

1 Civil Aviation Medicine Center, Civil Aviation Administration of China, Beijing, 100123, People’s Republic of China

2 Department of Clinical Laboratory, Civil Aviation General Hospital, Beijing, 100123, People’s Republic of China

3 Department of Cadiology, China-Japan Friendship Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, People’s Republic of China

4 Department of Neurosurgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of China

Abstract

Introduction: Previous studies on Brain and other Nervous System Cancers (BNSC) and aircrew have shown inconsistent results, possibly due to their relatively small sample sizes; therefore, the current study aimed to increase the precision of risk estimates.
Methods: Systematic searches of PubMed and Embase for pertinent studies up to August 2016 were performed and supplemented by manual reviews of bibliographies. The pooled standard incidence ratio (SIR) and corresponding 95% CIs were estimated with random effects models.
Results: Among the 903 studies retrieved, 7 studies (5 cohort studies and 2 pooled analyses) were included in the current meta-analysis. The pooled SIR (95% CI) of BNSC incidence in aircrew was 1.01 (0.77, 1.31) with no significant heterogeneity (I2 = 36.1%, P = .199). The null association persisted when the analysis was stratified by geographic area (Europe or America), publication year (before or after 2001), air population (pilots or cabin crew), cancer site (brain, nervous system, or brain/nervous system), and gender (male or female).
Conclusion: The current evidence is not sufficient to support a significant positive association between aircrew employment and BNSC risk. However, the interpretation and extrapolation of this meta-analysis are restricted by the possible impact exerted by health worker effect and potential clinical heterogeneity. More studies based on other populations, including Asian aircrews, are warranted.

Keywords


  1. Galeone C, Malerba S, Rota M, et al. A meta-analysis of alcohol consumption and the risk of brain tumours. Ann Oncol. 2013;24(2):514-523. doi:10.1093/annonc/mds432.
  2. Hammer GP, Blettner M, Langner I, Zeeb H. Cosmic radiation and mortality from cancer among male German airline pilots: extended cohort follow-up. Eur J Epidemiol. 2012;27(6):419-429. doi:10.1007/s10654-012-9698-2.
  3. Pukkala E, Auvinen A, Wahlberg G. Incidence of cancer among Finnish airline cabin attendants, 1967-92. BMj. 1995;311(7006):649-652.
  4. Band PR, Le ND, Fang R, et al. Cohort study of Air Canada pilots: Mortality, cancer incidence, and leukemia risk. Am J Epidemiol. 1996;143(2):137-143.
  5. Fogelholm R. Cancer among airline cabin attendants. BMJ. 1996;312(7022):53-54.
  6. Mllanov L, Dlmitrov D, Danon S. Cancer incidence in Republic of Bulgaria aircrew, 1964-1994. Aviat Space Environ Med. 1999;70(7):681-685.
  7. Haldorsen T, Reitan JB, Tveten U. Cancer incidence among Norwegian airline pilots. Scand J Work Environ Health. 2000;26(2):106-111. doi:10.5271/sjweh.519.
  8. Rafnsson V, Hrafnkelsson J, Tulinius H. Incidence of cancer among commercial airline pilots. Occup Environ Med. 2000;57(3):175-179.
  9. Haldorsen T, Reitan JB, Tveten U. Cancer incidence among Norwegian airline cabin attendants. Int J Epidemiol. 2001;30(4):825-830.
  10. Hammar N, Linnersjö A, Alfredsson L, Dammström BG, Johansson M, Eliasch H. Cancer incidence in airline and military pilots in Sweden 1961-1996. Aviat Space Environ Med. 2002;73(1):2-7.
  11. Reynolds P, Cone J, Layefsky M, Goldberg DE, Hurley S. Cancer incidence in California flight attendants (United States). Cancer Causes Control. 2002;13(4):317-324.
  12. dos Santos Silva I, De Stavola B, Pizzi C, Evans AD, Evans SA. Cancer incidence in professional flight crew and air traffic control officers: disentangling the effect of occupational versus lifestyle exposures. Int J Cancer. 2013;132(2):374-384. doi:10.1002/ijc.27612.
  13. Buja A, Lange JH, Perissinotto E, et al. Cancer incidence among male military and civil pilots and flight attendants: an analysis on published data. Toxicol Ind Health. 2005;21(10):273-282.
  14. Pukkala E, Aspholm R, Auvinen A, et al. Cancer incidence among 10,211 airline pilots: a Nordic study. Aviat Space Environ Med. 2003;74(7):699-706.
  15. Pukkala E, Helminen M, Haldorsen T, et al. Cancer incidence among Nordic airline cabin crew. Int J Cancer. 2012;131(12):2886-2897. doi:10.1002/ijc.27551.
  16. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012.
  17. Wells GA, Shea B, O’Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. http://www.ohri.ca/programs/clinical_epidemiology/nos_manual.pdf. Accessed May 1, 2016.
  18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
  19. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088- 1101.
  20. Band PR, Spinelli JJ, Ng VTY, Math M, Moody J, Gallagher RP. Mortality and cancer incidence in a cohort of commercial airline pilots. Aviat Space Environ Med. 1990;61(4):299-302.
  21. Bondy ML, Scheurer ME, Malmer B, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008;113(7 Suppl):1953-1968. doi:10.1002/cncr.23741.
  22. Gundestrup M, Storm HH. Radiation-induced acute myeloid leukaemia and other cancers in commercial jet cockpit crew: A population-based cohort study. Lancet. 1999;354(9195):2029-2031.
  23. Kirkeleit J, Riise T, Bjorge T, Christiani DC. The healthy worker effect in cancer incidence studies. Am J Epidemiol. 2013;177(11):1218-1224. doi:10.1093/aje/kws373.